Literature DB >> 27316542

Bistacrine derivatives as new potent antimalarials.

Ines Schmidt1, Gabriele Pradel2, Ludmilla Sologub2, Alexandra Golzmann2, Che J Ngwa2, Anna Kucharski1, Tanja Schirmeister3, Ulrike Holzgrabe4.   

Abstract

Linking two tacrine molecules results in a tremendous increase of activity against Plasmodia in comparison to the monomer. This finding prompted the synthesis of a library of monomeric and dimeric tacrine derivatives in order to derive structure-activity relationships. The most active compounds towards chloroquine sensitive Plasmodium strain 3D7 and chloroquine resistant strain Dd2 show IC50 values in the nanomolar range of concentration, low cytotoxicity and target the cysteine protease falcipain-2, which is essential for parasite growth.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimalarials; Bistacrines; Falcipain-2 inhibitors

Mesh:

Substances:

Year:  2016        PMID: 27316542     DOI: 10.1016/j.bmc.2016.06.003

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Transcriptional Profiling Defines Histone Acetylation as a Regulator of Gene Expression during Human-to-Mosquito Transmission of the Malaria Parasite Plasmodium falciparum.

Authors:  Che J Ngwa; Meike J Kiesow; Olga Papst; Lindsey M Orchard; Michael Filarsky; Alina N Rosinski; Till S Voss; Manuel Llinás; Gabriele Pradel
Journal:  Front Cell Infect Microbiol       Date:  2017-07-24       Impact factor: 5.293

2.  In silico Guided Drug Repurposing: Discovery of New Competitive and Non-competitive Inhibitors of Falcipain-2.

Authors:  Lucas N Alberca; Sara R Chuguransky; Cora L Álvarez; Alan Talevi; Emir Salas-Sarduy
Journal:  Front Chem       Date:  2019-08-06       Impact factor: 5.221

3.  South African Abietane Diterpenoids and Their Analogs as Potential Antimalarials: Novel Insights from Hybrid Computational Approaches.

Authors:  Thommas Musyoka; Özlem Tastan Bishop
Journal:  Molecules       Date:  2019-11-07       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.